The USGS and CDC have found antibodies for the 2009 H1N1 flu virus in blood samples from 70% of the sea otters studied
The discovery could lead to new therapies and better diagnostics, resulting in fewer hospitalizations of children with respiratory syncytial virus, the most common cause of admission in children under the age of 1.
A 3-D laboratory method has been developed to test asthma and allergy medications that could reduce the need to test the drugs on animals.
Spacelabs Healthcare is recalling the Arkon Anesthesia System with Version 2.0 Software due to a software defect that may cause serious adverse health consequences, including hypoxemia and death, according to an FDA announcement.
Hong Kong’s Department of Health is closely monitoring a cluster of 10 additional cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) reported to the World Health Organization (WHO) by the United Arab Emirates.
The enzyme SKG1 may be a useful target in treating asthma and boosting the effects of certain cancer therapies, according to researchers from Johns Hopkins Kimmel Cancer Center.
Grastek, a sublingual allergen extract manufactured by Merck & Co Inc, has received FDA approval as an immunotherapy for the treatment of Timothy grass pollen-induced allergic rhinitis.
The NIH grant will help the Icahn School of Medicine at Mount Sinai research pandemic preparedness and advance the understanding of influenza biology.
The protein DDX21 has been found to block the cellular replication process that takes place when an influenza virus infects a human cell, according to scientists at The University of Texas at Austin.
Scientists at Georgia Tech, Emory University, and the CDC are experimenting with a new delivery method for the influenza vaccination: a “Flu patch.” The small Band-Aid sized adhesive patch could potentially allow self-administration of the vaccine while also eliminating most of the pain of the traditional flu shot.